Tesla Motors Inc (TSLA) Slammed by Citron Research Tweet

Citron Research tweeted that it's shorting Tesla Motors Inc (NASDAQ:TSLA)

Mar 1, 2016 at 3:17 PM
facebook twitter linkedin


Infamous short seller Citron Research today tweeted that it foresees electric car manufacturer Tesla Motors Inc (NASDAQ:TSLA) falling to $100 per share by year's end due to supply and demand problems. As a result, TSLA stock sold off sharply, falling 3.3% to $185.56.

Looking closer, Citron is certainly not alone in its pessimistic outlook. Put buying has been extremely popular on TSLA recently; plus, short interest remains elevated. Specifically, roughly 31% of the stock's float is sold short, and it'd take them almost four days to repurchase their positions, at average daily volumes. 

Analysts are also skeptical of the stock. For instance, 10 of the 14 brokerage firms with coverage on TSLA say it's a "hold" or "sell."

Tesla Motors Inc (NASDAQ:TSLA) has fought back from its two-year low of $141.05 in February, but remains a long-term technical laggard. Specifically, the stock is 35.3% below July's annual high of $286.65. 

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Master Portfolio Trial
 


 


 
Special Offers from Schaeffer's Trading Partners